Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trichuris suis ova (TSO) as an additional therapy for rheumatoid arthritis patients with insufficient response to methotrexate. A prospective, double-blind, randomized, controlled monocenter study - TSORA

Trial Profile

Trichuris suis ova (TSO) as an additional therapy for rheumatoid arthritis patients with insufficient response to methotrexate. A prospective, double-blind, randomized, controlled monocenter study - TSORA

Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 May 2019

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms TSORA
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 29 Jul 2016 Status changed from recruiting to discontinued.
    • 11 Dec 2013 New source identified and integrated (German Clinical Trials Register; DRKS00005323).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top